EPA:EQS - FR0012882389 - Common Stock
The current stock price of EQS.PA is 45 EUR. In the past month the price decreased by -10.54%. In the past year, price decreased by -1.1%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
NXU.DE | NEXUS AG | 37.71 | 1.22B | ||
GPI.MI | GPI SPA | 4.82 | 500.14M | ||
CONTX.OL | CONTEXTVISION AB | 9.51 | 331.14M | ||
AGFB.BR | AGFA-GEVAERT NV | N/A | 152.19M | ||
CGM.PA | CEGEDIM SA | N/A | 146.64M | ||
ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 106.21M | ||
AJ91.DE | DOCCHECK AG | 11.63 | 61.35M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | 10.24 | 46.59M | ||
ALINS.PA | INTRASENSE SAS | N/A | 15.61M |
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );
EQUASENS
5 Allee de Saint-Cloud
Villers-les-Nancy GRAND EST FR
Employees: 1271
Phone: 33383159595
The current stock price of EQS.PA is 45 EUR. The price increased by 2.51% in the last trading session.
The exchange symbol of EQUASENS is EQS and it is listed on the Euronext Paris - Matif exchange.
EQS.PA stock is listed on the Euronext Paris - Matif exchange.
6 analysts have analysed EQS.PA and the average price target is 50.49 EUR. This implies a price increase of 12.2% is expected in the next year compared to the current price of 45. Check the EQUASENS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
EQUASENS (EQS.PA) has a market capitalization of 682.65M EUR. This makes EQS.PA a Small Cap stock.
EQUASENS (EQS.PA) currently has 1271 employees.
EQUASENS (EQS.PA) has a support level at 44.99 and a resistance level at 49.08. Check the full technical report for a detailed analysis of EQS.PA support and resistance levels.
The Revenue of EQUASENS (EQS.PA) is expected to grow by 9.72% in the next year. Check the estimates tab for more information on the EQS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EQUASENS (EQS.PA) has a dividend yield of 2.72%. The yearly dividend amount is currently 1.25. Check the full fundamental report for a detailed analysis of EQS.PA dividend history, reliability and sustainability.
EQUASENS (EQS.PA) will report earnings on 2025-09-26.
The PE ratio for EQUASENS (EQS.PA) is 18.83. This is based on the reported non-GAAP earnings per share of 2.39 and the current share price of 45 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EQS.PA.
ChartMill assigns a fundamental rating of 5 / 10 to EQS.PA. EQS.PA has only an average score on both its financial health and profitability.
Over the last trailing twelve months EQS.PA reported a non-GAAP Earnings per Share(EPS) of 2.39. The EPS decreased by -23.02% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 16.72% | ||
ROA | 9.1% | ||
ROE | 15.65% | ||
Debt/Equity | 0.12 |
6 analysts have analysed EQS.PA and the average price target is 50.49 EUR. This implies a price increase of 12.2% is expected in the next year compared to the current price of 45.
For the next year, analysts expect an EPS growth of 18.72% and a revenue growth 9.72% for EQS.PA